Abiopharma

News list

Cohen Fred E 🟢 acquired 150.0K shares of Intellia Therapeutics, Inc. (NTLA) at $9.35 ($1.4M) Transaction Date: Jan 05, 2026 | Filing ID: 006288

Full text

News bot Jan. 7, 2026, 9:09 p.m.
🔍 Cohen Fred E (Executive)

Company: Intellia Therapeutics, Inc. (NTLA)

Report Date: 2026-01-05
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 150,000
Detailed Transactions and Holdings:
- Acquired 150,000 shares of Common Stock at $9.35 per share (Direct)
  Date: 2026-01-05 | Code: P | equity_swap_involved: false | shares_owned_after: 207,453.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Reflects an open market purchase of shares of the Issuer's common stock by the Reporting Person in accordance with the Issuer's trading policies.
- F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.13 to $9.68, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased by the reporting person on January 5, 2026 at each separate price.